Free Express shipping over $250. Same day dispatch before 11am.
Catalogue & education only · Research use only
Longevity Research Peptides

Epithalon (AEDG): The Telomerase and Ageing Research Guide

Epithalon, also written Epitalon and known by its amino acid sequence Ala-Glu-Asp-Gly (AEDG), is the tetrapeptide that longevity science keeps returning to. It is best known in the laboratory for its studied capacity to activate telomerase, the enzyme that maintains the telomere caps on chromosomes, and for a research history rooted in pineal gland and gerontology work. This guide sets out what Epithalon is, the molecular mechanisms researchers study, the shape of the evidence and where it is still thin, and how the compound is verified before it reaches an Australian laboratory. NovaPeptides is Australian owned and Gold Coast based, has supplied research peptides to Australians for over three years, and ships every batch with a verified Novagen Certificate of Analysis. Epithalon is supplied strictly for laboratory and research use only and is not TGA approved for human use.

CompoundEpithalon (also Epitalon, Epithalone, the AEDG peptide)
SequenceAla-Glu-Asp-Gly, a synthetic tetrapeptide
Studied mechanismTelomerase (hTERT) induction and gene-expression modulation
Research areasTelomere biology, pineal and circadian regulation, gerontology
TGA statusNot approved, supplied for research use only
VerificationNovagen Certificate of Analysis on every batch, verifiable by a unique key

What is Epithalon?

Epithalon is a synthetic tetrapeptide, a chain of just four amino acids in the sequence alanine, glutamic acid, aspartic acid and glycine, written Ala-Glu-Asp-Gly and abbreviated AEDG. It is also spelled Epitalon and Epithalone, and all of those names refer to the same molecule. Epithalon was developed as a defined synthetic version of a peptide fraction originally isolated from the pineal gland, and over the following decades it has become one of the most studied compounds in longevity and ageing research.

Epithalon is supplied by NovaPeptides strictly for laboratory and research use. It is not TGA approved for human use, nothing on this page is medical advice or a treatment claim, and every research area described here is presented only in the context of published scientific study.

  • What it is: a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Gly (AEDG).
  • Other names: Epitalon, Epithalone, and the AEDG peptide, all the same molecule.
  • Why it is studied: for its reported capacity to activate telomerase and for its links to telomere biology and ageing.
  • Research heritage: derived from pineal gland peptide research within gerontology.
  • In the NovaPeptides range: supplied as a lyophilised research vial with a verifiable Novagen Certificate of Analysis.

How Epithalon is studied to work: telomerase and gene expression

The mechanism that defines Epithalon in the literature is telomerase activation. Telomerase is the enzyme that rebuilds telomeres, the protective caps of repetitive DNA at the ends of chromosomes that shorten a little each time a cell divides. In cell-culture studies, Epithalon has been reported to induce expression of the catalytic subunit of telomerase, known as hTERT, and to lengthen telomeres in human somatic cells such as fibroblasts, which are cell types that do not normally carry high telomerase activity.

Epithalon is not a classic membrane receptor agonist, so it does not have a single named surface receptor in the way a hormone-mimicking peptide does. Instead, the model researchers study is a gene-regulatory one. Short peptides like AEDG are proposed to interact with specific sequences in the promoter regions of DNA and with chromatin, influencing which genes are switched on or off. This epigenetic style of action is how the literature accounts for effects that reach beyond a single receptor pathway.

  • Telomerase (hTERT): induction of the catalytic subunit and telomere elongation reported in cultured human cells.
  • DNA promoter regions: a proposed site-specific interaction with short double-stranded DNA sequences.
  • Chromatin and gene expression: an epigenetic model in which AEDG modulates the transcription of multiple genes.
  • The pineal axis: studied for effects on melatonin rhythm and circadian regulation in ageing models.

Because Epithalon traces back to pineal gland research, a second strand of mechanism work looks at the pineal axis. Here the peptide is studied for its reported ability to restore melatonin secretion patterns and circadian rhythm in ageing animal models, a line of enquiry that connects it to sleep and biological-clock research as well as to telomere science.

What Epithalon is studied for

Across the published record, Epithalon appears in several overlapping research areas rather than a single one. The common thread is cellular ageing, approached from both the telomere side and the pineal side. The points below describe what the compound is studied for in research settings, not outcomes for any person.

  • Telomere biology: whether telomerase induction can slow or offset the telomere shortening associated with cellular ageing.
  • Cellular senescence: how cultured cells divide, behave and age when telomerase is upregulated.
  • Pineal and circadian regulation: melatonin rhythm, sleep patterns and the biological clock in aged models.
  • Oxidative stress markers: reported effects on lipid peroxidation and antioxidant defence in research models.
  • Gerontology and lifespan models: spontaneous tumour incidence and lifespan endpoints studied in rodents.

Each of these is a research context only. They describe questions investigators have asked of Epithalon in cells and animals, and in a smaller number of observational human studies. They are not statements that Epithalon does any of these things in people, and they are not a basis for any health, cosmetic or performance claim.

The Epithalon research landscape

Most of the foundational Epithalon research comes from a single centre, the St Petersburg Institute of Bioregulation and Gerontology in Russia, and the work of Vladimir Khavinson and colleagues, who first characterised the AEDG peptide. Their program spans in-vitro telomerase studies, rodent lifespan and tumour-incidence experiments, and long-running observational work in older human cohorts, which is why Epithalon has such a distinctive and internally consistent research story.

That concentration of the evidence in one research group is important context. Much of the strongest mechanistic data sits in cell culture and animal models, independent replication outside the originating institute is still limited, and several of the human reports are observational rather than large randomised controlled trials. Epithalon is best understood as a compound with an intriguing body of early research that the wider scientific community has not yet fully replicated or extended.

The literature supports Epithalon as a genuine object of telomerase and ageing research. It does not establish Epithalon as a proven anti-ageing treatment for people, and nothing here should be read as a health claim. NovaPeptides presents this honestly and supplies the compound for laboratory and research use only.

How Epithalon is handled in a research setting

Epithalon ships as a lyophilised, meaning freeze-dried, powder in a sealed vial. In this dry state it is stable and easy to transport, and it is prepared for study only when a laboratory is ready to use it. The notes below describe how research peptides of this type are generally handled by qualified investigators. They are general laboratory practice, not a protocol, and no dosing guidance is given because Epithalon is not for human use.

  • Storage: the lyophilised peptide is kept cold and away from light, with long-term storage usually frozen.
  • Reconstitution: investigators commonly reconstitute lyophilised peptides with bacteriostatic or sterile water using sterile technique.
  • Aliquoting: reconstituted material is often divided into single-session aliquots to limit freeze-thaw cycles.
  • Documentation: the batch number, Certificate of Analysis and preparation details are recorded for reproducibility.

Handling of Epithalon belongs in appropriate laboratory settings with suitably trained personnel. It is supplied for laboratory and research use only, it is not TGA approved for human use, and it must not be used for self-experimentation or human consumption.

Sourcing, purity and third-party verification

For a research compound, provenance is the whole point. A telomerase or ageing experiment is only as trustworthy as the identity and purity of the material behind it, so knowing exactly what is in the vial matters more than any marketing line. This is why every Epithalon batch NovaPeptides supplies is independently tested and shipped with a Certificate of Analysis you can verify yourself.

Every batchIndependently verified by Novagen Laboratories
  • Identity: confirmation that the material is the AEDG tetrapeptide it claims to be.
  • Purity: the measured purity of the specific batch, documented on the certificate.
  • Content: analytical confirmation of the peptide in the vial.
  • Traceability: a unique key you can check on Novagen's own verification register.

Why researchers choose NovaPeptides for Epithalon

NovaPeptides is an Australian owned, Gold Coast based supplier of research peptides. We have supplied Epithalon and the wider research peptide catalogue to Australians for over three years, and we dispatch locally to researchers Australia wide. The priority is straightforward: verified material, honest information, and no hype around what the science does and does not show.

  • Australian owned and Gold Coast based, with local dispatch to researchers Australia wide.
  • Over three years supplying research peptides to Australian laboratories and researchers.
  • A verified Novagen Certificate of Analysis on every batch, not just a single headline product.
  • Clear research-use-only positioning and honest, plainly stated information about the evidence.

Research use status in Australia

Epithalon is not an approved medicine. It has not been evaluated or approved by the Therapeutic Goods Administration for human use, and it is not sold or intended for human consumption, cosmetic use or performance use. NovaPeptides supplies Epithalon strictly as a research chemical for laboratory and research use only, and responsibility for lawful, appropriate handling sits with the researcher and their institution.

Epithalon (AEDG) is a research compound studied for telomerase activation and ageing science. It is supplied for laboratory and research use only, it is not TGA approved for human use, and it comes with a verified Novagen Certificate of Analysis on every batch from an Australian owned, Gold Coast based supplier.

Frequently asked questions

What is Epithalon?+

Epithalon is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG). It is also spelled Epitalon, and it is studied in the laboratory mainly for its reported capacity to activate telomerase, the enzyme that maintains the telomere caps on chromosomes. NovaPeptides supplies Epithalon strictly for laboratory and research use, with a verifiable Novagen Certificate of Analysis on every batch.

Is Epithalon the same as Epitalon and the AEDG peptide?+

Yes. Epithalon, Epitalon and Epithalone are all spellings of the same molecule, and the AEDG peptide is simply that same compound named after its four amino acid sequence, Ala-Glu-Asp-Gly. If you have researched any of those names, you are looking at the same tetrapeptide.

What is Epithalon studied for?+

In the published literature Epithalon is studied for telomerase activation and telomere biology, for pineal and circadian regulation including melatonin rhythm, for oxidative stress markers, and for lifespan and tumour-incidence endpoints in gerontology models. These are research contexts only. Epithalon is not TGA approved for human use and is supplied for research use only.

How is Epithalon thought to activate telomerase?+

In cell-culture studies Epithalon has been reported to induce hTERT, the catalytic subunit of telomerase, and to lengthen telomeres in human somatic cells such as fibroblasts. It is not a classic membrane receptor agonist. Instead the model researchers study is gene-regulatory, in which the short AEDG peptide interacts with promoter regions of DNA and chromatin to influence gene expression.

Where does Epithalon come from, and what is the pineal gland connection?+

Epithalon was developed as a defined synthetic version of a peptide fraction originally isolated from the pineal gland, within Russian gerontology research. That heritage is why one strand of the research studies its effect on the pineal axis, including melatonin secretion and circadian rhythm in ageing animal models, alongside the telomerase work.

How is Epithalon different from Epithalamin?+

Epithalamin is a natural polypeptide extract of the pineal gland, a mixture of components. Epithalon is the defined, single synthetic analogue, the four amino acid sequence Ala-Glu-Asp-Gly. So Epithalon is one precisely characterised molecule rather than a natural extract, which is part of why it is used in controlled research.

Is the Epithalon research reliable, and who carried out the studies?+

Much of the foundational Epithalon research comes from Vladimir Khavinson and the St Petersburg Institute of Bioregulation and Gerontology, spanning cell-culture, animal and observational human work. The mechanistic data is strongest in cells and animals, independent replication outside that group is still limited, and several human reports are observational rather than large randomised trials. It is an interesting early body of research that has not yet been fully replicated by the wider scientific community.

Is Epithalon approved by the TGA or legal to buy in Australia?+

Epithalon is not approved by the Therapeutic Goods Administration for human use and is not intended for human consumption. NovaPeptides supplies it as a research chemical for laboratory and research use only, never for human use, and lawful handling is the responsibility of the researcher and their institution.

Does Epithalon come with a Certificate of Analysis?+

Yes. Every Epithalon batch NovaPeptides supplies is independently tested and shipped with a Novagen Laboratories Certificate of Analysis. The COA documents the identity and purity of that specific batch and carries a unique key you can verify on the lab's own register, so you are not relying on a supplier's claim alone.

What form does Epithalon ship in, and how is it stored in a laboratory?+

Epithalon ships as a lyophilised, or freeze-dried, powder in a sealed vial, which is stable for transport. In a research setting the dry vial is kept cold and away from light, with long-term storage usually frozen, and it is reconstituted with sterile or bacteriostatic water using sterile technique only when it is ready to be studied. No dosing guidance is provided because Epithalon is for research use only.

Can I buy Epithalon in Australia from NovaPeptides?+

Yes. NovaPeptides is an Australian owned, Gold Coast based supplier that has provided research peptides to Australians for over three years, and Epithalon is dispatched Australia wide with a verified Novagen Certificate of Analysis on every batch. It is supplied strictly for laboratory and research use only and is not sold for human consumption.

Questions? Talk to us.

Message us on WhatsApp and we will walk you through the kits, the COAs, reconstitution and the dose tool.

Chat with us on WhatsApp
Join our community Chat with us